Skip to content

Spruce Biosciences, Inc.

SPRB· NasdaqCore metricsCIK 1683553

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -7.15%
Market cap
$123.83M
2.87M shares
Filings
369
$0.00
FY 2025−100.0% FY25 yoy
-$24.01M
Q3 2026N/M FY25 yoy
-$23.98M
Q3 2026N/M FY25 yoy
-$44.76M
Q3 2026derivedN/M FY24 yoy
-$8.51
Q3 2026N/M FY25 yoy
$87.69M
Q3 2026+26.2% FY25 yoy
$123.83M
—
—
1.9×
—
—

FY2025 figures · derived

Price

$43.0961.76%$69.57past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$10.09M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$4,911,000reported
FY 20232023-12-31$10,089,000reported
FY 20222022-12-31$0reported

Pharmaceutical preparations

Spruce Biosciences, Inc. is the 277th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Spruce Biosciences, Inc. · CIK 1683553 · Engraved from SEC EDGAR